Dosimetric Comparison of Brain Sparing Between HyperArc and GammaKnife for Single to Triple Brain Metastases
HyperArc demonstrated dosimetric performance comparable to or better than GammaKnife in brain sparing for single-to-triple metastases. These findings support HyperArc as an effective alternative for SRS planning.
Authors
- Shingo Ohira (ORCID: https://orcid.org/0000-0002-6170-1471)
- Naoyuki Kanayama (ORCID: https://orcid.org/0000-0003-0016-2213)
- Yoshihiro Ueda (ORCID: https://orcid.org/0000-0001-7151-9094)
- Kazuo Tarutani
- Kanji Mori
- Ayako Okamura
- Koji Konishi
Institutions
- Kansai Rosai Hospital (JP)
- Osaka International Cancer Institute (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17544
- Citations
- 1
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 1.88